About Jim Trenkle
Form D filings for Convergent Therapeutics in 2024 list Jim Trenkle as director.
Jim Trenkle first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jim Trenkle in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jim Trenkle works with at each company, as listed on that company's latest Form D.
Convergent Therapeutics, Inc. · Form D, Aug 13, 2024
ES
Eric Sullivan
Executive officer
JS
Jake Simson
Director
Tal Zaks
Director
PK
Philip Kantoff
CEO and director
AB
Alexander Brown
Executive officer
NB
Neil Bander
Executive officer and director